GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Phapros Tbk (ISX:PEHA) » Definitions » 5-Year EBITDA Growth Rate

PT Phapros Tbk (ISX:PEHA) 5-Year EBITDA Growth Rate : -17.20% (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is PT Phapros Tbk 5-Year EBITDA Growth Rate?

PT Phapros Tbk's EBITDA per Share for the three months ended in Sep. 2024 was Rp-6.35.

During the past 12 months, PT Phapros Tbk's average EBITDA Per Share Growth Rate was -77.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -20.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -17.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of PT Phapros Tbk was 34.80% per year. The lowest was -20.80% per year. And the median was -1.10% per year.


Competitive Comparison of PT Phapros Tbk's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, PT Phapros Tbk's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Phapros Tbk's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Phapros Tbk's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where PT Phapros Tbk's 5-Year EBITDA Growth Rate falls into.



PT Phapros Tbk 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


PT Phapros Tbk  (ISX:PEHA) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


PT Phapros Tbk 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of PT Phapros Tbk's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Phapros Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jl. Dr. Ide Anak Agung Gde Agung, Menara Rajawali Lt. 17, Kuningan, Jakarta Selatan, Jakarta, IDN, 12950
PT Phapros Tbk is a pharmaceutical company in Indonesia. The company is engaged in the industrial/manufacturing sector by producing and/or trading medicines, health instruments, chemical goods, and other similar goods in import, export, and other kinds of industry. The company operates through Over Counter (OTC), Ethical, Generic Drugs Bearing (OGB), and Toll Manufacturing segments.

PT Phapros Tbk Headlines

No Headlines